MYRIAD GENETICS - Dusseldorf Stock Exchang (MYD DU) stock market data APIs
€5.1829
-0.11(-2.1%)
as of January 2, 2026
Try our APIs with
free plan!
MYRIAD GENETICS - Dusseldorf Stock Exchang Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for MYD.DU.
Prev. Close
5.1829
Open
5.0703
High
5.3094
Low
5.0691
52 wk Range
3.28-14.4
Market Cap
1 751 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MYRIAD GENETICS - Dusseldorf Stock Exchang data using free add-ons & libraries
Get MYRIAD GENETICS - Dusseldorf Stock Exchang Fundamental Data
MYRIAD GENETICS - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get MYRIAD GENETICS - Dusseldorf Stock Exchang Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get MYRIAD GENETICS - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MYRIAD GENETICS - Dusseldorf Stock Exchang News
New
3 Unprofitable Stocks That Fall Short
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. A lack of profits can lead to trouble, but StockS...
Should Myriad Genetics Stock Stay in Your Portfolio Right Now?
Myriad Genetics, Inc. MYGN is well-poised to grow in the coming quarters due to its impressive cadence of product launches. The company is also progressing well in its refreshed long-term strategy to ...
Looking at the Narrative for Myriad Genetics After Price Target Revisions and Growth Concerns
Myriad Genetics has seen its price target nudged higher even as the core fair value estimate stays flat at about $8.52 per share, reflecting a cautious acknowledgment of recent operational progress. W...
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 3.7% in the afternoon session after the company signed an exclusive agreement with Zydus Lifesciences to commerci...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
